Research & Development

16 Jan 2020
- Drug Discovery
- Research & Development
Twist Bioscience announces strategic collaboration with Schrödinger for drug discovery

By PBR Staff Writer

Twist Bioscience, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a collaboration with Schrödinger, a company focused on transforming the way therapeutics are discovered with a physics-based computational platform, to bring the two companies’ technology platforms together to discover new antibody therapeutics against G-protein coupled receptor (GPCR) targets.
15 Jan 2020
Drug Discovery
Research & Development
Astellas, Adaptimmune sign deal to co-develop T-cell therapies for cancer

By PBR Staff Writer

Astellas Pharma has signed a deal worth up to $897.5m with Adaptimmune Therapeutics to co-develop and co-commercialise stem-cell derived allogeneic CAR-T and TCR T-cell therapies for cancer.
14 Jan 2020
Drug Discovery
Research & Development
BioMotiv and Atomwise sign AI partnership to transform therapeutic development

By PBR Staff Writer

BioMotiv, a mission-driven biopharma company, and Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, today announced a strategic collaboration to co-develop therapies.
14 Jan 2020
Drug Discovery
Research & Development
Charles River, Takeda announce scientific collaboration to identify and develop preclinical candidates

By PBR Staff Writer

Charles River announced a multi-year drug discovery collaboration with Takeda Pharmaceutical Company.
13 Jan 2020
Drug Discovery
Research & Development
NeuroBo Pharmaceuticals and Gemphire Therapeutics complete merger

By PBR Staff Writer

NeuroBo Pharmaceuticals, a clinical-stage biotechnology company focused on multimodal, disease-modifying therapies for neurodegenerative diseases, today reported that the previously announced merger between NeuroBo Pharmaceuticals and Gemphire Therapeutics closed on December 31, 2019.
13 Jan 2020
Drug Discovery
Research & Development
Eli Lilly to buy biopharmaceutical firm Dermira for $1.1bn

By PBR Staff Writer

Eli Lilly has agreed to acquire US-based biopharmaceutical company Dermira in an all-cash transaction valued at around $1.1bn.
10 Jan 2020
Drug Discovery
Research & Development
Gilead Sciences licences portfolio of HIV antibodies from The Rockefeller University

By PBR Staff Writer

Gilead Sciences announced that the company has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies (bNAbs) against HIV, including the two clinical-stage agents 3BNC117 and 10-1074.
10 Jan 2020
Drug Discovery
Research & Development
GHO Capital acquires CDMO Ardena

By PBR Staff Writer

Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, together with the existing management team has acquired Ardena, a specialist contract development and manufacturing organization (CDMO) focused on early phase drug development, from Mentha Capital.
10 Jan 2020
Drug Discovery
Research & Development
Empirico, Ionis collaborate to develop antisense oligonucleotide therapeutics

By PBR Staff Writer

Empirico has entered into a $660m deal with Ionis Pharmaceuticals to develop novel antisense oligonucleotide therapeutics.
09 Jan 2020
Drug Discovery
Research & Development
Schrödinger, Bayer collaborate to co-develop de novo design technology to accelerate drug discovery

By PBR Staff Writer

Schrödinger and Bayer announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs.

Drug Discovery

Research & Development

Formycon and Zydus sign exclusive agreement for FYB206 supply

Inductive Bio gains $21m ARPA-H funds for drug prediction models

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer

Suppliers

No data found

Research & Development

Twist Bioscience announces strategic collaboration with Schrödinger for drug discovery

Astellas, Adaptimmune sign deal to co-develop T-cell therapies for cancer

BioMotiv and Atomwise sign AI partnership to transform therapeutic development

Charles River, Takeda announce scientific collaboration to identify and develop preclinical candidates

NeuroBo Pharmaceuticals and Gemphire Therapeutics complete merger

Eli Lilly to buy biopharmaceutical firm Dermira for $1.1bn

Gilead Sciences licences portfolio of HIV antibodies from The Rockefeller University

GHO Capital acquires CDMO Ardena

Empirico, Ionis collaborate to develop antisense oligonucleotide therapeutics

Schrödinger, Bayer collaborate to co-develop de novo design technology to accelerate drug discovery

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found